Key Highlights

● IBM (NYSE:IBM) slid again, as new quantum computing breakthroughs meet the fallout from an earlier 25% one-day share collapse.

● Red Hat and hybrid cloud revenue grew 11% while Data revenue grew 19%, the plumbing enterprises need before AI agents can scale within their organizations.

● IBM trades at 19.7 times trailing and 17.3 times forward earnings, with roughly $13.8 billion of trailing free cash flow against an enterprise value near $266 billion.

● Transaction Processing fell 8% and guidance was cut, with cash drawing down sharply and gross margin compressing, explaining much of the prior collapse.

A 2% Slide That Barely Registers

International Business Machines Corporation (NYSE: IBM) closed the reference session at $221.74, down 2.08%, on 9.68 million shares. Relative volume of 0.75 means turnover ran about a quarter below the recent norm, quiet by the standards of the past three weeks.

That is what makes it interesting. Sixteen days earlier, IBM suffered one of the worst sessions in its modern history, and the market is still working out what it meant.

The 14 July Shock

On 14 July, IBM filed a Form 8-K containing preliminary second-quarter results and an open letter from Chairman and Chief Executive Arvind Krishna. The shares fell 25.21% that day, from $290.23 to $217.07, on 66.3 million shares, several times normal turnover.

The damage has not been repaired. Across the eleven sessions since, IBM has traded between $205.77 and $227.55, leaving it roughly 24% below the pre-announcement close. The shares are down 15.5% over twelve months and sit far beneath a 50-day moving average of $260.41 and a 200-day average of $270.76.

What Went Wrong: Mainframes and Missing Signatures

The problem was Infrastructure, specifically IBM Z, the mainframe franchise that still anchors much of the world's banking and insurance transaction processing. Krishna wrote that "numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall."

He blamed weakness in Z and transaction-processing software, clients redirecting capital spending toward servers and storage ahead of expected price rises, and industry-wide distraction from cybersecurity incidents. The product itself, he argued, is not the issue: z17 is running at nearly 130% of the prior program's revenue at the equivalent point.

Demand deferred versus demand lost is now the central question.

The Second Quarter in Full

IBM's formal results on 22 July confirmed the preliminary figures: revenue of $17.2 billion, up 1%. The mix was uneven. Software grew 5% to $7.8 billion, with hybrid cloud (largely Red Hat) up 11% and Data up 19%, but Transaction Processing, the software that runs on mainframes, down 8%. Consulting was flat at $5.3 billion. Infrastructure fell 7% to $3.8 billion, with Hybrid Infrastructure down 10% even as the newer Distributed Infrastructure line surged 37%.

Margins moved in opposite directions depending on the measure. GAAP gross margin slipped 100 basis points to 57.7% and pre-tax margin fell 90 basis points to 14.4%, yet non-GAAP operating margin improved to 19.2%. GAAP diluted earnings were $2.27, down 2%; operating earnings of $2.93 rose 5%.

Second-quarter free cash flow of $2.5 billion fell 12%, leaving first-half free cash flow flat at $4.8 billion. Cash and equivalents dropped to $8.2 billion from $14.6 billion at the end of 2025, against total debt of $62.0 billion.

Guidance Trimmed, Cash Flow Defended

The guidance change matters. In April, IBM expected full-year constant-currency revenue growth of "more than 5 percent." In July that became "four-to-five percent." Free-cash-flow guidance held: an increase of about $1 billion year over year, plus improved pre-tax margin expansion.

Chief Financial Officer James Kavanaugh said IBM stayed focused on productivity and cash generation despite late-quarter revenue headwinds. Krishna said the company is confident in its portfolio and sees business in the early innings of a structural shift toward AI.

The dividend held at $1.69 a quarter; with the September payment IBM will have paid dividends every year since 1916. The $6.76 annual rate yields about 3.05%, on a payout ratio near 60%.

The Quantum Push Is Real, and Expensive

The premise of a quantum renaissance survives scrutiny, though the bill is large.

In his 14 July letter, Krishna disclosed a letter of intent for a dedicated quantum wafer foundry backed by roughly $1 billion in CHIPS Act incentives from the U.S. Department of Commerce and about $1 billion of IBM cash, alongside more than $10 billion of quantum investment over five years. IBM reaffirmed its target of a large-scale fault-tolerant machine, Starling, by 2029.

On 23 July, IBM agreed to acquire HRL Laboratories, the research institution jointly owned by Boeing and General Motors, on undisclosed terms, with closing expected by the end of the third quarter. HRL brings silicon-spin qubit engineering, a different physical approach from IBM's superconducting qubits, plus quantum sensing and materials work.

On the reference session date, IBM published three quantum-advantage demonstrations with the University of Chicago, Qedma and Algorithmiq. In the Chicago work, IBM Quantum System Two encoded 70 logical qubits and ran 2,415 logical two-qubit operations in about 15 minutes, and, critically, produced verifiable results. Research director Jay Gambetta said IBM is "now firmly in the quantum advantage era."

Where AI Actually Shows Up

Quantum earns the headlines, but AI is where the money moves today. IBM's exposure runs through Red Hat and hybrid cloud, up 11%, and Data, up 19%, the plumbing enterprises need before AI agents can safely touch their records. IBM also launched Lightwell in July, a $5 billion commitment applying frontier AI to open-source security flaws, which shipped over 7,500 patches in a fortnight.

Competition, Bull Case and Bear Case

IBM competes with Microsoft, Amazon Web Services and Google in hybrid cloud and AI, Accenture in consulting, Oracle, SAP and Broadcom in software, and Dell and HPE in infrastructure. In quantum it faces Google, Quantinuum, IonQ and PsiQuantum.

The bull case is valuation and cash. IBM trades at 19.7 times trailing and 17.3 times forward earnings, with roughly $13.8 billion of trailing free cash flow against an enterprise value near $266 billion, plus a 3% dividend and 25 analysts averaging a Buy rating with a $244.16 target. If the mainframe deals were merely delayed, the derating overshot.

The bear case is that a 25% single-day repricing is rarely about one quarter. Transaction Processing fell 8%, guidance was cut, cash drew down sharply and gross margin is compressing, while Lightwell and quantum commitments climb. Susquehanna cut its target to $225 from $303 and Citi to $245 from $255.

Risks and What Comes Next

The risks are easy to name: whether deferred Z deals close, whether Transaction Processing stabilises, and whether the balance sheet absorbs multi-billion-dollar science bets without pressuring the dividend. Shareholder law firms have publicised investigations into the July disclosures, adding a legal overhang.

Third-quarter results in October are the next real test, alongside the HRL closing and any formal foundry agreement. Until then, IBM is priced as a value stock carrying an option on quantum, with the burden of proof squarely on the mainframe.

This article is general financial information and market commentary only. It does not constitute personal financial advice, an offer, a solicitation or a recommendation to buy, sell or hold any security. Investors should conduct their own research and consider obtaining professional advice before making investment decisions.